Patterns of Morphologic Alteration in Residual Rectal Carcinoma Following Preoperative Chemoradiation and their Association with Long-term Outcome

American Journal of Surgical Pathology

Volumn 28, Issue 2, 2004, Pages 215-223

  Shia, Jinru ^a   Guillem, Jose G ^a   Moore, Harvey G ^a   Tickoo, Satish K ^a,b   Qin, Jing ^a   Ruo, Leyo ^a   Suriawinata, Arief ^a,c   Paty, Philip B ^a   Minsky, Bruce D ^a   Weiser, Martin R ^a   Temple, Larissa K ^a   Wong, W Douglas ^a   Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Neoadjuvant therapy; Posttreatment rectal cancer; Prognosis; Rectal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MUCIN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; EOSINOPHILIA; FEMALE; FIBROSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREOPERATIVE PERIOD; PROGNOSIS; RECTUM CARCINOMA; STROMA CELL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR NECROSIS; ULTRASOUND;

ADENOCARCINOMA; BIOPSY; DRUG THERAPY; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREOPERATIVE CARE; RADIOTHERAPY; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 9144219576     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200402000-00009     Document Type: Article

References (31)

1. rd, Choti MA, Cohen AM, et al. NCCN Practice Guidelines for Colorectal Cancer. Oncology (Huntingt). 2000;14:203-212.
2. Bosset JF, Magnin V, Maingon P, et al. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys. 2000;46:323-327.
3. Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg. 1995;221:778-786.
4. Clinical Outcomes Group. Improving outcomes in colorectal cancer: guidance on commissioning cancer services. NHS Executive. 1997; EL(97):66.
5. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet. 2001;358:1291-1304.
6. Compton CC, Fielding P, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
7. th ed. London: Chapman and Hall, 1990.
8. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, et al. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer. 2000;88:1544-1548.
9. Fisher ER, Paik SM, Rockette H, et al. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol. 1989; 20:159-163.
10. Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum. 1997;40: 515-522.
11. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303-1306.
12. Medich D, McGinty J, Parda D, et al. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications. Dis Colon Rectum. 2001; 44:1123-1128.
13. Minsky BD. Sphincter preservation in rectal cancer: preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin Radiat Oncol. 1998;8:30-35.
14. Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phvs. 2000;48:1075-1080.
15. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response: specific immune response has only a systemic effect - a histopathological and immunohistochemical study. BMC Cancer. 2001; 1:7.
16. Nagtegaal ID, Marijnen CAM, Kranenbarg E, et al. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol. 2002;197:20-27.
17. Nielsen HJ, Hansen U, Christensen IBJ, et al. Independent prognostic value of eosinophil as mast cell infiltration in colorectal cancer tissue. J Pathol. 1999;189:487-495.
18. Onaitis MW, Noone RB, Hartwig M, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcome from a 13 year institutional experience. Ann Surg. 2001;235:778-785.
19. Ota DM. Preoperative radiation therapy for rectal cancer: benefits and controversies. Ann Surg Oncol. 1996;3:419-420.
20. Rich TA, Skibber JM, Ajani JA et al., Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:1025-1029.
21. Ruo L, Guillem JG, Minsky BD, et al. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis. 2002;17:54-58.
22. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002;236:75-81.
23. Rusch V, Klimstra D, Venkatraman E, et al. Aberrant p53 expression predicts clinical resistance to Cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res. 1995;55:5038-5042.
24. Saltz LB, Minsky B. Adjuvant therapy of cancers of the colon and rectum. Surg Clin North Am. 2002;82:1035-1058.
25. Shia J, Tickoo SK, Guillem JG, et al. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol. 2002;26:863-872.
26. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980-987.
27. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathological response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum. 2002;45:895-903.
28. Valentini V, Coco C, Cellini N et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys. 1998;40:1067-1075.
29. Valentini V, Coco C, Cellini N et al. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys. 1999;45:1175-1184.
30. Valentini V, Coco C, Picciocchi A, et al. Does down-staging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys. 2002;53:664-674.
31. Wagman R, Minsky BD, Cohen AM, et al. Sphincter preservation with pre-operative radiation therapy (RT) and coloanal anastomoses: long term follow up. Int J Radiat Oncol Biol Phys. 1998;42:51-57.